Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fatma S. Hafez"'
Publikováno v:
Polish Journal of Pathology, Vol 74, Iss 3, Pp 171-181 (2023)
Podoplanin (PDPN) is a lymphatic endothelial marker expressed by a range of human malignancies in which it has been shown to contribute to tumor progression and metastasis. However, there is a lack of the studies, examining the function of PDPN in th
Externí odkaz:
https://doaj.org/article/be90541928cc403a8bfc218d79113293
Autor:
Fatma S. Hafez, Bahaaeddin Sa'di, M. Safa-Gamal, Y.H. Taufiq-Yap, Moath Alrifaey, Mehdi Seyedmahmoudian, Alex Stojcevski, Ben Horan, Saad Mekhilef
Publikováno v:
Energy Strategy Reviews, Vol 45, Iss , Pp 101013- (2023)
In recent years, increasing interest has been shown in targeting energy efficiency as a roadmap for carbon mitigation, limiting energy use, improving buildings’ energy performance, and reducing energy consumption for achieving sustainable buildings
Externí odkaz:
https://doaj.org/article/be365576ba3a4da0ac6ab63f17bcd0c3
Publikováno v:
Open Journal of Obstetrics and Gynecology. 13:699-711
Publikováno v:
Histology and histopathology. 37(5)
Colorectal cancer is one of the most prevalent types of tumors worldwide. P16ᴵᴺᴷ⁴ᵃ is a widely used immunohistochemical marker for high-risk HPV infection. The purpose of this study is to explore the relationship between P16 expression as a
Autor:
Mona A. Salem, Sherif F. El-Khamisy, Asmaa M. M. M. Salama, Mohamed M. Mouneer, Abdel Wahab El Ghareeb, Hesham Elghazaly, Marwa A. Abdel-Wahed, Shaza A. Habib, Maha A Abo-Shadi, Omar R. Alfarouk, Ahmed Barakat, Mark J. Dunning, Shimaa A. Metwally, Sara H. Agwa, Fatma S. Hafez, Manar M. Moneer, Nasra F. Abdel Fattah, Ahmed M. Osman, Manal Mohamed El-mahdy, Amany M Helal, Ahmed A. El Sherif, Tarek Hashem, Samah A. Loutfy
Publikováno v:
Cancer Research. 81:2512-2512
Introduction: Breast cancer (BC) is a multifactorial disease, that is attributed to non-familial factors such as environmental or genetic factors that play a vital role in the development of the disease. BRCA1/2 mutations represent a high risk of bre